| __timestamp | BioMarin Pharmaceutical Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 621276000 | 19764000 |
| Thursday, January 1, 2015 | 737887000 | 67426000 |
| Friday, January 1, 2016 | 907234000 | 59752000 |
| Sunday, January 1, 2017 | 1071860000 | 65383000 |
| Monday, January 1, 2018 | 1175948000 | 70165000 |
| Tuesday, January 1, 2019 | 1344582000 | 44738000 |
| Wednesday, January 1, 2020 | 1336183000 | 39457000 |
| Friday, January 1, 2021 | 1375760000 | 97894000 |
| Saturday, January 1, 2022 | 1612370000 | 115306000 |
| Sunday, January 1, 2023 | 1842161000 | 453552000 |
| Monday, January 1, 2024 | 2273680000 |
Igniting the spark of knowledge
In the dynamic world of biopharmaceuticals, understanding financial health is crucial. Over the past decade, BioMarin Pharmaceutical Inc. has consistently outperformed HUTCHMED (China) Limited in terms of gross profit. From 2014 to 2023, BioMarin's gross profit surged by nearly 200%, peaking at $1.84 billion in 2023. In contrast, HUTCHMED's growth, while significant, was more modest, with a 23-fold increase, reaching $453 million in the same year.
This stark contrast highlights BioMarin's robust market strategy and product portfolio, which have enabled it to capture a larger market share. Meanwhile, HUTCHMED's growth trajectory, though slower, indicates a steady expansion in the competitive Chinese market. As both companies continue to innovate, investors and stakeholders should keep a keen eye on their financial performance to gauge future potential.
Gross Profit Trends Compared: Johnson & Johnson vs BioMarin Pharmaceutical Inc.
AstraZeneca PLC and BioMarin Pharmaceutical Inc.: A Detailed Gross Profit Analysis
Amgen Inc. and HUTCHMED (China) Limited: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Sanofi and HUTCHMED (China) Limited
Gross Profit Analysis: Comparing GSK plc and BioMarin Pharmaceutical Inc.
Biogen Inc. vs BioMarin Pharmaceutical Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Dr. Reddy's Laboratories Limited or BioMarin Pharmaceutical Inc.
Annual Revenue Comparison: BioMarin Pharmaceutical Inc. vs HUTCHMED (China) Limited
Gross Profit Analysis: Comparing BioMarin Pharmaceutical Inc. and Vericel Corporation
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Catalent, Inc. vs HUTCHMED (China) Limited
Gross Profit Comparison: Perrigo Company plc and HUTCHMED (China) Limited Trends